Newswise,
September 24, 2015 - In cancer patients
nearing the end of life, certain subtypes of delirium—specifically, hypoactive
and "mixed" delirium—are a strong indicator that death will come
soon, reports a study in Psychosomatic
Medicine: Journal of Biobehavioral Medicine, the official journal of theAmerican Psychosomatic Society. The
journal is published by Wolters Kluwer.
"Terminally
ill patients with the hypoactive or mixed subtypes of delirium showed a higher
probability of imminent death, with even earlier mortality among younger
patients," according to the new research by Sung-Wan Kim, MD, and
colleagues of Chonnam National University Medical School Gwangju, Republic of
Korea. They believe their findings might help make more accurate predictions of
survival in patients nearing the end of life.
Shorter
Survival in Patients with Hypoactive/Mixed Delirium
The researchers looked at the relationship between delirium and survival time in 322 patients with terminal cancer entering palliative care. Delirium refers to confusion, altered awareness, or altered thoughts. It can result from many different illnesses, medications, and other causes.
Delirium
was divided into subtypes according to standard DSM-5 criteria: hyperactive
delirium, with increased motor activity, loss of control, and restlessness;
hypoactive delirium, with decreased activity, decreased speech, and reduced
awareness.
Patients with normal psychomotor activity or fluctuating activity
levels were classified as having "mixed" delirium.
About
30 percent of patients were diagnosed with delirium on entering palliative
care.
Of these, the delirium subtype was hyperactive in about 15 percent of
patients, hypoactive in 34 percent, and mixed in 51 percent.
Survival
time after entering palliative care was shorter for patients with delirium:
median 17 days, compared to 28 days for those without delirium. However, the
difference was significant only for patients with hypoactive or mixed
delirium—with median survival times of 14 and 15 days, respectively.
These
differences remained significant after adjustment for other factors. For
patients with hyperactive delirium, survival was not different from that in
patients without delirium.
While
delirium was more common in older patients, the effects on time to death were
actually stronger in younger patients. That was consistent with previous
studies suggesting shorter survival times in younger patients diagnosed with
delirium
Why
are different delirium subtypes associated with differing survival times? It
may have to do with differences in the underlying causes of and treatment
responses. Hyperactive delirium is commonly related to reversible causes, such
as medication side effects.
"In
contrast, hypoactive delirium is generally related to hypoxia [decreased oxygen
levels], metabolic disturbances, and multi-organ failure," Dr. Kim
explains. "Therefore, hypoactive delirium could be associated with a
higher mortality rate than hyperactive delirium."
Dr. Kim adds, "Also, the earlier mortality in younger patients overturns a conventional assumption for survival prediction of delirium. Although delirium was more prevalent in older patients, as known, the irony is that delirium predicted shorter survival in younger patients."
Accurate
predictions of survival time in terminally ill patients are important for many
reasons—"in terms of ensuring good clinical decision making, developing
care strategies, and preparing for the end of life in a dignified manner."
The researchers conclude, "Thus, the present findings could facilitate
more precise predictions of survival, allowing families to prepare for the
patient’s death."
Articles:
“Differential Associations Between Delirium and Mortality According to Delirium
Subtype and Age: A Prospective Cohort Study.” (doi:
10.1097/PSY.0000000000000239)
No comments:
Post a Comment